XML 53 R36.htm IDEA: XBRL DOCUMENT v3.22.4
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of Assumptions Used to Estimate the Fair Value of Stock Options Granted The following table summarizes the assumptions used to estimate the fair value of the 2022 CEO stock option grant:
Year Ended December 31,
202220212020
Risk-free interest rate3.01 %**
Expected term (in years)****
Expected volatility70 %**
Expected dividend yield— %**
* Not applicable because no stock options were granted during the period.
** Each Vesting Price Threshold for the 2022 CEO grant has a unique expected term ranging from 3.4 years to 4.1 years.
Schedule of Stock Option Activity
The following table summarizes stock option activity for the years ended December 31, 2022, 2021, and 2020:

Number of SharesWeighted Average Exercise PriceWeighted Average Remaining Contractual Term (Years)Aggregate Intrinsic Value (in thousands)
Outstanding at December 31, 2019
4,458,611 $12.30 5.8$115,501 
Granted— — 
Exercised(1,001,411)6.39 81,181 
Expired(1,380)11.82 
Forfeited(56,580)11.33 
Outstanding at December 31, 2020
3,399,240 14.06 4.9503,174 
Granted— — 
Exercised(423,824)6.55 43,525 
Expired(4,100)10.54 
Forfeited(17,960)11.78 
Outstanding at December 31, 2021
2,953,356 15.16 4.0147,812 
Granted700,000 50.63 
Exercised(937,217)27.14 32,858 
Expired(7,900)4.06 
Forfeited(10,280)12.28 
Outstanding at December 31, 2022
2,697,959 $20.25 5.1$45,867 
Exercisable at December 31, 2022
1,997,959 $9.60 3.6$45,867 
Schedule of Restricted Stock Unit Activity
The following table summarizes RSU activity for the years ended December 31, 2022, 2021, and 2020:

Number of SharesWeighted Average Grant Date Fair Value
Non-vested and outstanding at December 31, 2019
1,022,835 $31.39 
Granted589,692 60.47 
Vested(270,609)31.29 
Forfeited(176,915)32.01 
Non-vested and outstanding at December 31, 2020
1,165,003 46.04 
Granted488,462 108.98 
Vested(354,130)43.39 
Forfeited(89,806)62.72 
Non-vested and outstanding at December 31, 2021
1,209,529 70.99 
Granted606,203 52.63 
Vested(403,648)58.63 
Forfeited(221,364)70.30 
Non-vested and outstanding at December 31, 2022
1,190,720 $65.97 
Schedule of Components of Stock-based Compensation Expense
The following table summarizes the components of our stock-based compensation expense by instrument type for the years ended December 31, 2022, 2021, and 2020 (in thousands):

Year Ended December 31,
202220212020
RSUs$35,290 $19,382 $10,745 
Stock options2,790 3,839 4,164 
Common stock awards to Board of Directors750 623 370 
Total stock-based compensation expense$38,830 $23,844 $15,279 
Schedule of Stock-based Compensation Expense Included in Condensed Consolidated Statements of Operations
Stock-based compensation expense for RSUs, stock options, and issuances of common stock to the Board of Directors is included in the following line items in the accompanying consolidated statements of operations for the years ended December 31, 2022, 2021, and 2020 (in thousands):

Year Ended December 31,
202220212020
Cost of revenue
Subscriptions$996 $1,199 $943 
Professional services5,309 3,131 1,477 
Operating expenses
Sales and marketing9,152 5,426 2,821 
Research and development12,523 5,224 2,718 
General and administrative10,850 8,864 7,320 
Total stock-based compensation expense$38,830 $23,844 $15,279